Viewing Study NCT05067127

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-25 @ 5:08 AM

Ignite Modification Date: 2025-12-26 @ 4:12 AM

Study NCT ID: NCT05067127

Status: COMPLETED

Last Update Posted: 2025-08-06

First Post: 2021-09-23

Is NOT Gene Therapy: False

Has Adverse Events: True

Brief Title: Phase III Study Assessing the Efficacy and Safety of Pegcetacoplan in Patients With C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis

Sponsor: Apellis Pharmaceuticals, Inc.

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module Adverse Events Module Baseline Characteristics Module Participant Flow Module